PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Annals of Pediatric Endocrinology & Metabolism10.6065/apem.2017.22.1.68201722168A 1-month-old infant with chylomicronemia due toGPIHBP1gene mutation treated by plasmapheresisMo Kyung Jung, Juhyun Jin, Hyun Ok Kim, Ahreum Kwon, Hyun Wook Chae, Seok Jin Kang, Duk Hee Kim, Ho-Seong Kimhttps://synapse.koreamed.org/pdf/10.6065/apem.2017.22.1.68, https://synapse.koreamed.org/DOIx.php?id=10.6065/apem.2017.22.1.68, http://e-apem.org/upload/pdf/apem-22-68.pdf
Journal of Clinical Lipidology10.1016/j.jacl.2022.05.0232022163e46-e47Acquired Chylomicronemia Due to Autoantibodies Against GPIHBP1Mansi Katkar, Namra Butt, Alan Brownhttps://api.elsevier.com/content/article/PII:S1933287422001222?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1933287422001222?httpAccept=text/plain
Journal of Clinical Lipidology10.1016/j.jacl.2016.03.0092016104915-921.e4Clinical and genetic features of 3 patients with familial chylomicronemia due to mutations in GPIHBP1 geneClaudio Rabacchi, Sergio D'Addato, Silvia Palmisano, Tiziano Lucchi, Stefano Bertolini, Sebastiano Calandra, Patrizia Tarugihttps://api.elsevier.com/content/article/PII:S1933287416300447?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1933287416300447?httpAccept=text/plain
Journal of Clinical Lipidology10.1016/j.jacl.2014.08.010201486635-639Familial chylomicronemia syndrome and response to medium-chain triglyceride therapy in an infant with novel mutations in GPIHBP1Zahid Ahmad, Don P. Wilsonhttps://api.elsevier.com/content/article/PII:S1933287414003146?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1933287414003146?httpAccept=text/plain
Neuropathology10.1046/j.1440-1789.2002.00470.x2002224365-366Four-month-old male infant with generalized muscle weaknessTeruo Shirabehttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1440-1789.2002.00470.x, https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1440-1789.2002.00470.x, http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1440-1789.2002.00470.x/fullpdf
Journal of Clinical Lipidology10.1016/j.jacl.2018.01.0112018122506-510A novel mutation in GPIHBP1 causes familial chylomicronemia syndromeMartine Paquette, Robert A. Hegele, Guillaume Paré, Alexis Baasshttps://api.elsevier.com/content/article/PII:S193328741830031X?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S193328741830031X?httpAccept=text/plain
Atherosclerosis10.1016/j.atherosclerosis.2016.07.4732016252e72-e73A case of severe chylomicronaemia syndrome, in a patient with normal lipoprotein lipase activity, due to a previously unidentified mutation in the GPIHBP1 geneP. Downie, G. Baylyhttps://api.elsevier.com/content/article/PII:S0021915016307742?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0021915016307742?httpAccept=text/plain
Indian Journal of Pediatrics10.1007/s12098-021-04053-42022894411-411Homozygous ARHGDIA Gene Mutation in an 11-Month-Old Infant with Steroid-Resistant Nephrotic SyndromeAditya Narayan, Pediredla Karunakar, Sriram Krishnamurthy, Bobbity Deepthi, Divakar Josehttps://link.springer.com/content/pdf/10.1007/s12098-021-04053-4.pdf, https://link.springer.com/article/10.1007/s12098-021-04053-4/fulltext.html, https://link.springer.com/content/pdf/10.1007/s12098-021-04053-4.pdf
Atherosclerosis Supplements10.1016/s1567-5688(11)70623-72011121131622 CHILHOOD-ONSET CHYLOMICRONEMIA WITH REDUCED PLASMA LPL ACTIVITY AND MASS: IDENTIFICATION OF A NOVEL GPIHBP1 MUTATIONJ. Maqne, I. Coca-Prieto, O. Kroupa, P. Gonzalez-Santos, G. Olivecrona, E. Ehrenborg, P. Valdivielsohttps://api.elsevier.com/content/article/PII:S1567568811706237?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1567568811706237?httpAccept=text/plain
Reactions Weekly10.1007/s40278-019-59062-0201917441163-163Interferon-β-1ahttp://link.springer.com/content/pdf/10.1007/s40278-019-59062-0.pdf, http://link.springer.com/article/10.1007/s40278-019-59062-0/fulltext.html, http://link.springer.com/content/pdf/10.1007/s40278-019-59062-0.pdf